Journal of Medical Ethics 36 (2):111-115 (2010)
AbstractThe academic literature in research ethics has been marked in the past decade by a much broader focus on the need for the protection of developing communities subjected to international clinical trials. Because of the proximity of the revision of the Declaration of Helsinki, completed in October 2008, most papers have addressed the issue of a double standard of care following the use of placebo. However, other no less important issues, such as interactions between the lifestyles structures of low-income communities and the efficiency of risk-minimising procedures also deserve attention. The purpose of this paper is to discuss forms of uncertainty involved in clinical trials in poor and low-income countries that are not addressed by conventional methods of risk assessment. Furthermore, the increase in size of risks that are identified by conventional assessment methods will be addressed. Besides, the difficulty in properly applying risk-minimising procedures will be discussed. Finally, this paper proposes the involvement of research ethics committees in the risk evaluation process and the establishment of national ethics evaluation systems
Similar books and articles
Ethical Challenges of HIV Clinical Trials in Developing Countries.Joe Thomas - 1998 - Bioethics 12 (4):320–327.
Off‐Shoring Clinical Research: Exploitation and the Reciprocity Constraint.Agomoni Ganguli Mitra - 2013 - Developing World Bioethics 13 (3):111-118.
For-Profit Clinical Trials in Developing Countries—Those Troublesome Patient Benefits.Udo Schuklenk - 2010 - American Journal of Bioethics 10 (6):52-54.
End of Life Pediatric Research: What About the Ethics? [REVIEW]Danielle Laudy - 2009 - Journal of Academic Ethics 7 (1-2):87-91.
'Moral Taint' or Ethical Responsibility? Unethical Information and the Problem of HIV Clinical Trials in Developing Countries.Deborah Zion - 1998 - Journal of Applied Philosophy 15 (3):231–239.
Clinical Trials and Scid Row: The Ethics of Phase 1 Trials in the Developing World.Jonathan Kimmelman - 2007 - Developing World Bioethics 7 (3):128–135.
The Definition of Adequate Care in Externally Sponsored Clinical Trials: The Terminological Controversy About the Concept “Standard of Care”.Hans-Jörg Ehni - 2006 - Science and Engineering Ethics 12 (1):123-130.
What Makes Placebo-Controlled Trials Unethical?Franklin G. Miller & Howard Brody - 2002 - American Journal of Bioethics 2 (2):3 – 9.
The Context of Ethical Problems in Medical Volunteer Work.Anji Wall - 2011 - HEC Forum 23 (2):79-90.
Evaluating the First-in-Human Clinical Trial of a Human Embryonic Stem Cell-Based Therapy.Audrey R. Chapman & Courtney C. Scala - 2012 - Kennedy Institute of Ethics Journal 22 (3):243-261.
Placebos and the UK Medical Research Council — and the Consumer Perspective.Joan Box - 2004 - Science and Engineering Ethics 10 (1):95-101.
Uncertainty and the Ethics of Clinical Trials.Sven Ove Hansson - 2006 - Theoretical Medicine and Bioethics 27 (2):149-167.
A Closer Look at the Bad Deal Trial: Beyond Clinical Equipoise.Lynn A. Jansen - 2005 - Hastings Center Report 35 (5):29-36.
Are Phase 1 Trials Therapeutic? Risk, Ethics, and Division of Labor.James A. Anderson & Jonathan Kimmelman - 2014 - Bioethics 28 (3):138-146.
Opinions of Researchers Based in the Uk on Recruiting Subjects From Developing Countries Into Randomized Controlled Trials.Sam K. Newton & John Appiah-Poku - 2007 - Developing World Bioethics 7 (3):149–156.
Added to PP
Historical graph of downloads
Citations of this work
Ethical Approval in Developing Countries is Not Optional.Edwin R. van Teijlingen & Padam P. Simkhada - 2012 - Journal of Medical Ethics 38 (7):428-430.
Vulnerability.Thiago Cunha & Volnei Garrafa - 2016 - Cambridge Quarterly of Healthcare Ethics 25 (2):197-208.
“Who Am I to Judge These Things”: Intersectional Dimensions of Self-Silencing of People with a Neuromuscular Disease in a Clinical Trial.Floor Cuijpers, Maaike Muntinga, Minne Bakker, Gönül Dilaver, Mariëtte van den Hoven & Petra Verdonk - 2022 - International Journal of Feminist Approaches to Bioethics 15 (2):51-75.
Enhancing Capacity of Ethics Review Committees in Developing Countries: The Kenyan Example.Gloria Manyonyi, Walter Jaoko, Kirana Bhatt, Simon Langat, Gaudensia Mutua, Bashir Farah, Jacquelyne Nyange, Joyce Olenja, Julius Oyugi, Sabina Wakasiaka, Maureen Khaniri, Keith Fowke, Rupert Kaul & Omu Anzala - 2014 - South African Journal of Bioethics and Law 7 (2):59.
References found in this work
Unethical Trials of Interventions to Reduce Perinatal Transmission of the Human Immunodeficiency Virus in Developing Countries.Peter Lurie & Sidney M. Wolfe - 2012 - In Stephen Holland (ed.), Arguing About Bioethics. Routledge. pp. 479.
Status of National Research Bioethics Committees in the WHO African Region.Joses Kirigia, Charles Wambebe & Amido Baba-Moussa - 2005 - BMC Medical Ethics 6 (1):1-7.
""Research in Developing Countries: Taking" Benefit" Seriously.Leonard H. Glantz, George J. Annas, Michael A. Grodin & Wendy K. Mariner - 1998 - Hastings Center Report 28 (6):38.
Ethics of Placebo Controlled Trials in Developing Countries.Reidar K. Lie - 1998 - Bioethics 12 (4):307–311.
Use and Abuse of Empirical Knowledge in Contemporary Bioethics.Jan Helge Solbakk - 2004 - Medicine, Health Care and Philosophy 7 (1):5-16.